company string | company_tickers list | cik string | sic string | office string | industry string | exchanges list | filing_type string | filing_date string | filing_accession_number string | filing_processed bool | parsed_toc_keys string | parsed_prospectus_summary_valid bool | parsed_prospectus_summary string | parsed_prospectus_summary_word_count int64 | parsed_risk_factors_valid bool | parsed_risk_factors string | parsed_risk_factors_word_count int64 | parsed_legal_matters_valid bool | parsed_legal_matters string | parsed_legal_matters_word_count int64 | filing_url string | filing_images list |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLOUDASTRUCTURE, INC. | [
"CSAI"
] | 0001709628 | 7370 | 06 Technology | Services-Computer Programming, Data Processing, Etc. | [
"Nasdaq"
] | S-1 | 2024-09-11 00:00:00 | 0001683168-24-006311 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001709628/000168316824006311/cloudastructure_s1.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1/A | 2025-09-25 00:00:00 | 0001493152-25-014878 | true | CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; PROSPECTUS SUMMARY; ABOUT THIS OFFERING; RISK FACTORS; USE OF PROCEEDS; CAPITALIZATION; DILUTION; DESCRIPTION OF SECURITIES; MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS; PLAN OF DISTRIBUTION; DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECU... | false | ./parsed_sections/prospectus_summary/2025/BIAFW_bioaffinit_prospectus_summary.txt | 3,207 | true | ./parsed_sections/risk_factors/2025/BIAFW_bioaffinit_risk_factors.txt | 3,389 | false | ./parsed_sections/legal_matters/2025/BIAFW_bioaffinit_legal_matters.txt | 4,104 | https://www.sec.gov/Archives/edgar/data/0001712762/000149315225014878/forms-1a.htm | [
"https://www.sec.gov/Archives/edgar/data/0001712762/000149315225014878/forms-1a_001.jpg"
] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1 | 2025-09-24 00:00:00 | 0001493152-25-014730 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315225014730/forms-1.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1/A | 2025-09-15 00:00:00 | 0001493152-25-013294 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315225013294/forms-1a.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1 | 2025-08-29 00:00:00 | 0001641172-25-025990 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000164117225025990/forms-1.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1/A | 2025-05-05 00:00:00 | 0001641172-25-008629 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000164117225008629/forms-1a.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1 | 2025-05-02 00:00:00 | 0001641172-25-008170 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000164117225008170/forms-1.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1 | 2025-04-11 00:00:00 | 0001641172-25-003892 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000164117225003892/forms-1.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1 | 2024-11-27 00:00:00 | 0001493152-24-048047 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315224048047/forms-1.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1 | 2024-09-11 00:00:00 | 0001493152-24-035849 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315224035849/forms-1.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1 | 2024-04-04 00:00:00 | 0001493152-24-013214 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315224013214/forms-1.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1 | 2023-09-20 00:00:00 | 0001493152-23-033238 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315223033238/forms-1.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1/A | 2022-08-18 00:00:00 | 0001493152-22-023475 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315222023475/forms-1a.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1/A | 2022-08-05 00:00:00 | 0001493152-22-021392 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315222021392/forms-1a.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1/A | 2022-08-02 00:00:00 | 0001493152-22-021028 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315222021028/forms-1a.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1/A | 2022-07-28 00:00:00 | 0001493152-22-020463 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315222020463/forms-1a.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1/A | 2022-06-16 00:00:00 | 0001493152-22-016924 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315222016924/forms-1a.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1/A | 2022-05-25 00:00:00 | 0001493152-22-014997 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315222014997/forms-1a.htm | [] |
bioAffinity Technologies, Inc. | [
"BIAFW"
] | 0001712762 | 8731 | 08 Industrial Applications and Services | Services-Commercial Physical & Biological Research | [
"Nasdaq"
] | S-1 | 2022-04-25 00:00:00 | 0001493152-22-010771 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001712762/000149315222010771/forms-1.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2025-08-08 00:00:00 | 0001213900-25-073401 | true | PROSPECTUS SUMMARY; THE OFFERING; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; RISK FACTORS; USE OF PROCEEDS; DIVIDEND POLICY; DILUTION; DESCRIPTION OF SECURITIES WE ARE OFFERING; PLAN OF DISTRIBUTION; LEGAL MATTERS; WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION OF CERTAIN INFORMATION BY REFERENCE | false | ./parsed_sections/prospectus_summary/2025/LGVN_longeveron_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/LGVN_longeveron_risk_factors.txt | 772 | false | ./parsed_sections/legal_matters/2025/LGVN_longeveron_legal_matters.txt | 839 | https://www.sec.gov/Archives/edgar/data/0001721484/000121390025073401/ea0252186-s1a1_longeve.htm | [
"https://www.sec.gov/Archives/edgar/data/0001721484/000121390025073401/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001721484/000121390025073401/image_002.jpg"
] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-08-04 00:00:00 | 0001213900-25-071302 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390025071302/ea0251483-s1_longeve.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2024-08-06 00:00:00 | 0001213900-24-065710 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390024065710/ea0210664-s1_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2024-06-28 00:00:00 | 0001213900-24-057196 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390024057196/ea0208597-s1_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2024-05-21 00:00:00 | 0001213900-24-045580 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390024045580/ea0206591-s1a1_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2024-04-30 00:00:00 | 0001213900-24-037313 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390024037313/ea0204771-s1_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2024-04-16 00:00:00 | 0001213900-24-033507 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390024033507/ea0203922-s1a1_longeve.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2024-04-05 00:00:00 | 0001213900-24-030874 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390024030874/ea0202023-03.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2024-04-03 00:00:00 | 0001213900-24-029926 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390024029926/ea0202023-02.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2024-03-19 00:00:00 | 0001213900-24-024093 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390024024093/ea0202023-01.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2024-01-29 00:00:00 | 0001213900-24-007380 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390024007380/ea192322-s1_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2023-11-15 00:00:00 | 0001213900-23-087605 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390023087605/ea188517-s1_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2023-08-11 00:00:00 | 0001213900-23-066272 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390023066272/fs12023a2_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2023-07-28 00:00:00 | 0001213900-23-060847 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390023060847/fs12023a1_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2023-06-27 00:00:00 | 0001213900-23-051787 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390023051787/fs12023_longeveroninc.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2021-12-15 00:00:00 | 0001213900-21-065443 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390021065443/ea152367-s1_longeveroninc.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-02-10 00:00:00 | 0001213900-21-007899 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390021007899/ea135094-s1a3_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-02-08 00:00:00 | 0001213900-21-007260 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390021007260/ea134819-s1a2_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-02-03 00:00:00 | 0001213900-21-006475 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390021006475/ea134523-s1a1_longeveron.htm | [] |
Longeveron Inc. | [
"LGVN"
] | 0001721484 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2021-01-19 00:00:00 | 0001213900-21-002924 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001721484/000121390021002924/ea133523-s1_longeveron.htm | [] |
Tri-County Financial Group, Inc. | [
"TYFG"
] | 0001725262 | 6022 | 02 Finance | State Commercial Banks | [
"OTC"
] | S-1/A | 2025-07-18 00:00:00 | 0001641172-25-020165 | true | ABOUT THIS PROSPECTUS; INDUSTRY AND MARKET DATA; IMPLICATIONS OF BEING AN EMERGING GROWTH COMPANY; SUMMARY; SELECTED FINANCIAL DATA; RISK FACTORS; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; USE OF PROCEEDS; MARKET PRICE AND DIVIDEND INFORMATION; BUSINESS OVERVIEW; MANAGEMENT DISCUSSION AND ANALYSIS; SECURITY... | false | ./parsed_sections/prospectus_summary/2025/TYFG_tri_prospectus_summary.txt | 6,039 | false | ./parsed_sections/risk_factors/2025/TYFG_tri_risk_factors.txt | 18,449 | false | ./parsed_sections/legal_matters/2025/TYFG_tri_legal_matters.txt | 14,477 | https://www.sec.gov/Archives/edgar/data/0001725262/000164117225020165/forms-1a.htm | [
"https://www.sec.gov/Archives/edgar/data/0001725262/000164117225020165/audit_002.jpg"
] |
Tri-County Financial Group, Inc. | [
"TYFG"
] | 0001725262 | 6022 | 02 Finance | State Commercial Banks | [
"OTC"
] | S-1 | 2025-06-16 00:00:00 | 0001641172-25-015271 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001725262/000164117225015271/forms-1.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2025-08-01 00:00:00 | 0001213900-25-070112 | true | About This Prospectus and Exchange Rates; Prospectus Summary; Risk Factors; Special Note Regarding Forward-Looking Statements; Use of Proceeds; Dividend Policy; Market Information; Management’s Discussion and Analysis of Financial Condition and Results of Operations; Business; Management; Executive and Director Compens... | false | ./parsed_sections/prospectus_summary/2025/INM_inmed_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/INM_inmed_risk_factors.txt | 30,092 | false | ./parsed_sections/legal_matters/2025/INM_inmed_legal_matters.txt | 12,214 | https://www.sec.gov/Archives/edgar/data/0001728328/000121390025070112/ea0249334-s1a1_inmed.htm | [
"https://www.sec.gov/Archives/edgar/data/0001728328/000121390025070112/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001728328/000121390025070112/image_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001728328/000121390025070112/image_003.jpg",
"https://www.sec.gov/Archives/edgar/data/00017283... |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-07-09 00:00:00 | 0001213900-25-062428 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390025062428/ea0248402-s1_inmed.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2024-12-30 00:00:00 | 0001213900-24-113340 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390024113340/ea0226237-s1a1_inmedpharma.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2024-12-23 00:00:00 | 0001213900-24-111992 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390024111992/ea0225519-s1_inmedpharma.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2023-11-08 00:00:00 | 0001213900-23-084811 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390023084811/ea187877-s1_inmedpharma.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2022-12-07 00:00:00 | 0001213900-22-078237 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390022078237/ea169785-s1_inmedpharma.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2022-10-12 00:00:00 | 0001213900-22-063371 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390022063371/ea167011-s1_inmedpharma.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2022-06-24 00:00:00 | 0001213900-22-034949 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390022034949/ea162066-s1a1_inmed.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2022-06-21 00:00:00 | 0001213900-22-033953 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390022033953/ea161783-s1_inmedpharma.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2021-07-13 00:00:00 | 0001213900-21-036589 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390021036589/ea144036-s1_inmedpharma.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2021-03-05 00:00:00 | 0001213900-21-013737 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000121390021013737/ea137020-s1_inmedpharma.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2020-10-15 00:00:00 | 0001193125-20-270298 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000119312520270298/d904092ds1a.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2020-10-08 00:00:00 | 0001193125-20-266437 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000119312520266437/d904092ds1a.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2020-09-15 00:00:00 | 0001193125-20-245509 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000119312520245509/d904092ds1a.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2020-07-21 00:00:00 | 0001193125-20-196244 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000119312520196244/d904092ds1a.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2020-07-06 00:00:00 | 0001193125-20-187245 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000119312520187245/d904092ds1a.htm | [] |
InMed Pharmaceuticals Inc. | [
"INM"
] | 0001728328 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2020-06-19 00:00:00 | 0001193125-20-174157 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001728328/000119312520174157/d904092ds1.htm | [] |
XORTX Therapeutics Inc. | [
"XRTX"
] | 0001729214 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2025-09-25 00:00:00 | 0001104659-25-093362 | true | ABOUT THIS PROSPECTUS; PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; EXCHANGE RATE DATA; USE OF PROCEEDS; DIVIDEND POLICY; CAPITALIZATION; DILUTION; DESCRIPTION OF SHARE CAPITAL; DESCRIPTION OF WARRANTS; TAXATION; PLAN OF DISTRIBUTION; EXPENSES OF THE OFFERING; LE... | false | ./parsed_sections/prospectus_summary/2025/XRTX_xortx_prospectus_summary.txt | 3 | true | ./parsed_sections/risk_factors/2025/XRTX_xortx_risk_factors.txt | 2,175 | true | ./parsed_sections/legal_matters/2025/XRTX_xortx_legal_matters.txt | 70 | https://www.sec.gov/Archives/edgar/data/0001729214/000110465925093362/tm2522032-8_f1.htm | [
"https://www.sec.gov/Archives/edgar/data/0001729214/000110465925093362/lg_xortxtherapeutics-4clr.jpg",
"https://www.sec.gov/Archives/edgar/data/0001729214/000110465925093362/lg_dboralcapital-4clr.jpg",
"https://www.sec.gov/Archives/edgar/data/0001729214/000110465925093362/fc_therapeuticspipe-4clr.jpg"
] |
XORTX Therapeutics Inc. | [
"XRTX"
] | 0001729214 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2024-11-15 00:00:00 | 0001104659-24-119763 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001729214/000110465924119763/tm2428455-1_f1.htm | [] |
XORTX Therapeutics Inc. | [
"XRTX"
] | 0001729214 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-09-21 00:00:00 | 0001104659-22-101944 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001729214/000110465922101944/tm2222207-9_f1a.htm | [] |
XORTX Therapeutics Inc. | [
"XRTX"
] | 0001729214 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2022-09-12 00:00:00 | 0001104659-22-099008 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001729214/000110465922099008/tm2222207-7_f1a.htm | [] |
XORTX Therapeutics Inc. | [
"XRTX"
] | 0001729214 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2022-09-08 00:00:00 | 0001104659-22-098458 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001729214/000110465922098458/tm2222207-3_f1.htm | [] |
XORTX Therapeutics Inc. | [
"XRTX"
] | 0001729214 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2021-10-12 00:00:00 | 0001753926-21-000563 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001729214/000175392621000563/g082387_f1a.htm | [] |
XORTX Therapeutics Inc. | [
"XRTX"
] | 0001729214 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2021-10-04 00:00:00 | 0001753926-21-000527 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001729214/000175392621000527/g082371_f1a.htm | [] |
XORTX Therapeutics Inc. | [
"XRTX"
] | 0001729214 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1/A | 2021-09-16 00:00:00 | 0001753926-21-000445 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001729214/000175392621000445/g082332_f1a.htm | [] |
XORTX Therapeutics Inc. | [
"XRTX"
] | 0001729214 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | F-1 | 2021-08-12 00:00:00 | 0001753926-21-000333 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001729214/000175392621000333/g082291_f1.htm | [] |
BIT ORIGIN Ltd | [
"BTOG"
] | 0001735556 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | F-1 | 2025-08-25 00:00:00 | 0001410578-25-001881 | true | CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; PROSPECTUS SUMMARY; SUMMARY CONSOLIDATED FINANCIAL STATEMENTS; RISK FACTORS; USE OF PROCEEDS; DETERMINATION OF OFFERING PRICE; MARKET INFORMATION AND DIVIDEND POLICY; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; BUSINESS; MA... | false | ./parsed_sections/prospectus_summary/2025/BTOG_bit_prospectus_summary.txt | 157 | true | ./parsed_sections/risk_factors/2025/BTOG_bit_risk_factors.txt | 21,431 | false | ./parsed_sections/legal_matters/2025/BTOG_bit_legal_matters.txt | 453 | https://www.sec.gov/Archives/edgar/data/0001735556/000141057825001881/btog-20241231xf1.htm | [
"https://www.sec.gov/Archives/edgar/data/0001735556/000141057825001881/btog-20241231xf1010.jpg",
"https://www.sec.gov/Archives/edgar/data/0001735556/000141057825001881/btog-20241231xf1013.jpg"
] |
BIT ORIGIN Ltd | [
"BTOG"
] | 0001735556 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | F-1/A | 2021-09-24 00:00:00 | 0001104659-21-119383 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001735556/000110465921119383/tmb-20210921xf1a.htm | [] |
BIT ORIGIN Ltd | [
"BTOG"
] | 0001735556 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | F-1/A | 2021-08-27 00:00:00 | 0001104659-21-110613 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001735556/000110465921110613/tmb-20210827xf1.htm | [] |
BIT ORIGIN Ltd | [
"BTOG"
] | 0001735556 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | F-1 | 2021-08-09 00:00:00 | 0001104659-21-102298 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001735556/000110465921102298/tm2120144d1_f1.htm | [] |
BIT ORIGIN Ltd | [
"BTOG"
] | 0001735556 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | F-1 | 2019-12-19 00:00:00 | 0001104659-19-074430 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001735556/000110465919074430/tm1925250d1_f1.htm | [] |
BIT ORIGIN Ltd | [
"BTOG"
] | 0001735556 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | F-1/A | 2018-09-28 00:00:00 | 0001144204-18-051365 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001735556/000114420418051365/tv503435_f1a.htm | [] |
BIT ORIGIN Ltd | [
"BTOG"
] | 0001735556 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | F-1/A | 2018-09-17 00:00:00 | 0001144204-18-049577 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001735556/000114420418049577/tv502689_f1a.htm | [] |
BIT ORIGIN Ltd | [
"BTOG"
] | 0001735556 | 6199 | 09 Crypto Assets | Finance Services | [
"Nasdaq"
] | F-1 | 2018-08-24 00:00:00 | 0001144204-18-046137 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001735556/000114420418046137/tv501372_f1.htm | [] |
Lendbuzz Inc. | [
"LBZZ"
] | 0001736734 | 6141 | 02 Finance | Personal Credit Institutions | [] | S-1 | 2025-09-12 00:00:00 | 0001193125-25-201851 | true | Prospectus Summary; Risk Factors; Special Note Regarding Forward-Looking Statements; Market, Industry, and Other Data; Use of Proceeds; Dividend Policy; Capitalization; Dilution; Management’s Discussion and Analysis of Financial Condition and Results of Operations; Business; Management; Executive and Director Compensat... | true | ./parsed_sections/prospectus_summary/2025/LBZZ_lendbuzz_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/LBZZ_lendbuzz_risk_factors.txt | 25,182 | false | ./parsed_sections/legal_matters/2025/LBZZ_lendbuzz_legal_matters.txt | 41 | https://www.sec.gov/Archives/edgar/data/0001736734/000119312525201851/d715014ds1.htm | [
"https://www.sec.gov/Archives/edgar/data/0001736734/000119312525201851/g715014g00a02.jpg",
"https://www.sec.gov/Archives/edgar/data/0001736734/000119312525201851/g715014g01a01.jpg",
"https://www.sec.gov/Archives/edgar/data/0001736734/000119312525201851/g715014g19w54.jpg",
"https://www.sec.gov/Archives/edgar/d... |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | F-1/A | 2025-09-29 00:00:00 | 0001213900-25-093089 | true | Introduction; Prospectus Summary; The Offering; Summary Consolidated Financial Data; Risk Factors; Special Notes Regarding Forward-Looking Statements and Industry Data; Use of Proceeds; Dividend Policy; Capitalization; Enforceability of Civil Liabilities; Corporate History and Structure; Management’s Discussion and Ana... | false | ./parsed_sections/prospectus_summary/2025/CHR_cheer_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/CHR_cheer_risk_factors.txt | 15,873 | true | ./parsed_sections/legal_matters/2025/CHR_cheer_legal_matters.txt | 158 | https://www.sec.gov/Archives/edgar/data/0001738758/000121390025093089/ea0259112-f1a3_cheer.htm | [
"https://www.sec.gov/Archives/edgar/data/0001738758/000121390025093089/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001738758/000121390025093089/image_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001738758/000121390025093089/image_003.jpg"
] |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | F-1/A | 2025-09-24 00:00:00 | 0001213900-25-091135 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001738758/000121390025091135/ea0257794-f1a2_cheer.htm | [] |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | F-1/A | 2025-09-03 00:00:00 | 0001213900-25-084109 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001738758/000121390025084109/ea0255465-f1a1_cheer.htm | [] |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | F-1 | 2025-08-07 00:00:00 | 0001213900-25-073105 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001738758/000121390025073105/ea0250732-f1_cheer.htm | [] |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | F-1/A | 2021-06-17 00:00:00 | 0001213900-21-032965 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001738758/000121390021032965/ea142790-f1a1_glorystarnew.htm | [] |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | F-1 | 2021-06-01 00:00:00 | 0001213900-21-030314 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001738758/000121390021030314/ea141937-f1_glorystarnew.htm | [] |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | S-1/A | 2018-08-13 00:00:00 | 0001213900-18-010811 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001738758/000121390018010811/fs12018a3_tkksymphony.htm | [] |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | S-1/A | 2018-08-09 00:00:00 | 0001213900-18-010497 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001738758/000121390018010497/fs12018a2_tkksymphony.htm | [] |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | S-1/A | 2018-08-06 00:00:00 | 0001213900-18-010263 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001738758/000121390018010263/fs12018a1_tkksymphony.htm | [] |
Cheer Holding, Inc. | [
"CHR"
] | 0001738758 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq"
] | S-1 | 2018-07-30 00:00:00 | 0001213900-18-009839 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001738758/000121390018009839/fs12018_tkksymphony.htm | [] |
ADVENT TECHNOLOGIES HOLDINGS, INC. | [
"ADNH"
] | 0001744494 | 3690 | 04 Manufacturing | Miscellaneous Electrical Machinery, Equipment & Supplies | [
"OTC"
] | S-1 | 2025-08-18 00:00:00 | 0001829126-25-006432 | true | PROSPECTUS SUMMARY; RISK FACTORS; CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS; HUDSON GLOBAL TRANSACTION; USE OF PROCEEDS; PLAN OF DISTRIBUTION; DIVIDEND POLICY; CAPITALIZATION; DILUTION; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; BUSINESS; MANAGEMENT; EXECUTIVE... | false | ./parsed_sections/prospectus_summary/2025/ADNH_advent_prospectus_summary.txt | 20,820 | false | ./parsed_sections/risk_factors/2025/ADNH_advent_risk_factors.txt | 124 | false | ./parsed_sections/legal_matters/2025/ADNH_advent_legal_matters.txt | 47,093 | https://www.sec.gov/Archives/edgar/data/0001744494/000182912625006432/adventtech_s1.htm | [
"https://www.sec.gov/Archives/edgar/data/0001744494/000182912625006432/img_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001744494/000182912625006432/img_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001744494/000182912625006432/img_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001744494/000... |
ADVENT TECHNOLOGIES HOLDINGS, INC. | [
"ADNH"
] | 0001744494 | 3690 | 04 Manufacturing | Miscellaneous Electrical Machinery, Equipment & Supplies | [
"OTC"
] | S-1 | 2022-04-21 00:00:00 | 0001140361-22-015410 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001744494/000114036122015410/ny20003896x1_s-1.htm | [] |
ADVENT TECHNOLOGIES HOLDINGS, INC. | [
"ADNH"
] | 0001744494 | 3690 | 04 Manufacturing | Miscellaneous Electrical Machinery, Equipment & Supplies | [
"OTC"
] | S-1/A | 2021-03-26 00:00:00 | 0001140361-21-010325 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001744494/000114036121010325/nt10020125x5_s1a.htm | [] |
ADVENT TECHNOLOGIES HOLDINGS, INC. | [
"ADNH"
] | 0001744494 | 3690 | 04 Manufacturing | Miscellaneous Electrical Machinery, Equipment & Supplies | [
"OTC"
] | S-1 | 2021-02-16 00:00:00 | 0001140361-21-004824 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001744494/000114036121004824/nt10020125x1_s-1.htm | [] |
ADVENT TECHNOLOGIES HOLDINGS, INC. | [
"ADNH"
] | 0001744494 | 3690 | 04 Manufacturing | Miscellaneous Electrical Machinery, Equipment & Supplies | [
"OTC"
] | S-1/A | 2018-11-09 00:00:00 | 0001140361-18-042791 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001744494/000114036118042791/s002355x5_s1a.htm | [] |
ADVENT TECHNOLOGIES HOLDINGS, INC. | [
"ADNH"
] | 0001744494 | 3690 | 04 Manufacturing | Miscellaneous Electrical Machinery, Equipment & Supplies | [
"OTC"
] | S-1 | 2018-10-25 00:00:00 | 0001140361-18-041301 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001744494/000114036118041301/s002355x4_s1.htm | [] |
Quantum Computing Inc. | [
"QUBT"
] | 0001758009 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2025-07-29 00:00:00 | 0001213900-25-068335 | true | Cautionary Note Regarding Forward-Looking Statements; Prospectus Summary; Risk Factors; Use of Proceeds; Determination of Offering Price; Selling Stockholders; Plan of Distribution; Legal Matters; Experts; Incorporation of Certain Documents by Reference; Where You Can Find More Information | false | ./parsed_sections/prospectus_summary/2025/QUBT_quantum_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/QUBT_quantum_risk_factors.txt | 4,634 | false | ./parsed_sections/legal_matters/2025/QUBT_quantum_legal_matters.txt | 3,089 | https://www.sec.gov/Archives/edgar/data/0001758009/000121390025068335/ea0250356-s1_quantum.htm | [] |
Quantum Computing Inc. | [
"QUBT"
] | 0001758009 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2025-07-03 00:00:00 | 0001213900-25-061351 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001758009/000121390025061351/ea0248083-s1_quantum.htm | [] |
Quantum Computing Inc. | [
"QUBT"
] | 0001758009 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2025-01-22 00:00:00 | 0001213900-25-005606 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001758009/000121390025005606/ea0228261-s1_quantum.htm | [] |
Quantum Computing Inc. | [
"QUBT"
] | 0001758009 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2024-12-20 00:00:00 | 0001213900-24-110795 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001758009/000121390024110795/ea0225439-s1_quantum.htm | [] |
Quantum Computing Inc. | [
"QUBT"
] | 0001758009 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1/A | 2020-06-02 00:00:00 | 0001213900-20-013954 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001758009/000121390020013954/ea122612-s1a2_quantumcom.htm | [] |
Quantum Computing Inc. | [
"QUBT"
] | 0001758009 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1/A | 2020-06-02 00:00:00 | 0001213900-20-013899 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001758009/000121390020013899/ea122558-s1a1_quantumcom.htm | [] |
Quantum Computing Inc. | [
"QUBT"
] | 0001758009 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2020-05-21 00:00:00 | 0001213900-20-013249 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001758009/000121390020013249/ea122052-s1_quantumcomputing.htm | [] |
Quantum Computing Inc. | [
"QUBT"
] | 0001758009 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1/A | 2019-12-04 00:00:00 | 0001213900-19-025301 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001758009/000121390019025301/fs12019a1_quantumcomp.htm | [] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.